sodium selenate has been researched along with morphine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hernández-Gallegos, Z; Lehmann, PA | 1 |
Bidlack, JM; DeVita, EK; Hilbert, JE; Neumeyer, JL; Xiong, W; Zhang, A | 1 |
Bidlack, JM; Knapp, BI; Neumeyer, JL; Peng, X | 1 |
Bidlack, JM; Cohen, DJ; Knapp, BI; Neumeyer, JL; Sromek, AW; Zhang, B; Zhang, T | 1 |
Aricò, G; Parenti, C; Pasquinucci, L; Ronsisvalle, G; Turnaturi, R | 1 |
1 review(s) available for sodium selenate and morphine
Article | Year |
---|---|
Multitarget opioid ligands in pain relief: New players in an old game.
Topics: Analgesics, Opioid; Animals; Humans; Ligands; Molecular Structure; Pain; Receptors, Opioid | 2016 |
4 other study(ies) available for sodium selenate and morphine
Article | Year |
---|---|
A Free-Wilson/Fujita-Ban analysis and prediction of the analgesic potency of some 3-hydroxy- and 3-methoxy-N-alkylmorphinan-6-one opioids.
Topics: Analgesics; Animals; Female; Mice; Morphinans; Regression Analysis; Software; Structure-Activity Relationship | 1990 |
2-aminothiazole-derived opioids. Bioisosteric replacement of phenols.
Topics: Animals; Benzomorphans; CHO Cells; Cricetinae; Morphinans; Morphine Derivatives; Narcotics; Phenols; Radioligand Assay; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship; Thiazoles | 2004 |
Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
Topics: Animals; CHO Cells; Cricetinae; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Ligands; Molecular Conformation; Morphinans; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship | 2006 |
Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors.
Topics: Animals; Benzylamines; Binding, Competitive; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Kinetics; Morphinans; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2012 |